Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.

Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.

The Akt activation inhibitor triciribine and the farnesyltransferase inhibitor tipifarnib have modest to little activity in clinical trials when used as single agents. In this article, preclinical data show that the combination is more effective than single agents both in cultured cells and in vivo....

书目详细资料
Main Authors:	Balasis, M, Forinash, K, Chen, Y, Fulp, W, Coppola, D, Hamilton, A, Cheng, J, Sebti, S
格式:	Journal article
语言:	English
出版:	2011

相似书籍

Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers
由: Sathish Kumar Mungamuri, et al.
出版: (2013-10-01)

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
由: Flores Juana M, et al.
出版: (2010-07-01)

Proteolytic processing of ErbB4 in breast cancer.
由: Maija Hollmén, et al.
出版: (2012-01-01)

Proliferation of colorectal cancer is promoted by two signaling transduction expression patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK.
由: Yong-Liang Yao, et al.
出版: (2013-01-01)

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
由: Sho Ueno, et al.
出版: (2020-06-01)

Expression of c-erbB3 protein in primary breast carcinomas.
由: Naidu, R., et al.
出版: (1998)

Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models
由: Raman Devarajan, et al.
出版: (2023-09-01)

Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1.
由: Guangyuan Li, et al.
出版: (2014-01-01)

Molecular markers (c-erbB-2, p53) in breast cancer.
由: Piotr Zukrowski, et al.
出版: (2009-01-01)

Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2/COX2/MDR1 axis
由: Yun Liu, et al.
出版: (2023-05-01)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.
由: Diego Alvarado, et al.
出版: (2017-01-01)

c-erbB-2 expression in different histological types of invasive breast carcinoma.
由: Soomro, S, et al.
出版: (1991)

c-erbB-2 oncoprotein in screen-detected breast carcinoma: an immunohistological study.
由: Soomro, S, et al.
出版: (1993)

Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer
由: Schillaci Roxana, et al.
出版: (2012-02-01)

Farnesyltransferase inhibitors.
由: Hahn, S, et al.
出版: (2001)

BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors
由: Evelina Miele, et al.
出版: (2020-02-01)

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
由: Meysam Moghbeli, et al.
出版: (2019-01-01)

Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells
由: Yanli Bi, et al.
出版: (2021-04-01)

A Functionally Significant Cross-talk between Androgen Receptor and ErbB2 Pathways in Estrogen Receptor Negative Breast Cancer
由: Ali Naderi, et al.
出版: (2008-06-01)

Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
由: Gillian Farnie, et al.
出版: (2013-01-01)

Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors.
由: Yoon Sin Oh, et al.
出版: (2011-01-01)

Mathematical modelling of Her2 (ErbB2) PI3K/AKT signalling pathways during breast carcinogenesis to include PTPD2
由: Bing Ji, et al.
出版: (2020-06-01)

Transcriptome analysis of basal and luminal tumor-initiating cells in ErbB2-driven breast cancer
由: Nicholas Borcherding, et al.
出版: (2015-06-01)

The role of protease activity in ErbB biology.
由: Blobel, C, et al.
出版: (2009)

Spinal nerve injury causes upregulation of ErbB2 and ErbB3 receptors in rat dorsal root ganglia
由: Mizobuchi S, et al.
出版: (2013-02-01)

Melatonin upregulates ErbB1 and ErbB4, two primary implantation receptors, in pre-implantation mouse embryos
由: Ghazaleh Moshkdanian, et al.
出版: (2017-06-01)

Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase.
由: Hast, M, et al.
出版: (2009)

Significance of microRNA-targeted ErbB signaling pathway genes in cardiomyocyte differentiation
由: Akram Gholipour, et al.
出版: (2023-06-01)

Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs
由: Tingting Lin, et al.
出版: (2019-04-01)

Betacellulin-Induced α-Cell Proliferation Is Mediated by ErbB3 and ErbB4, and May Contribute to β-Cell Regeneration
由: Young-Sun Lee, et al.
出版: (2021-01-01)

c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent.
由: Giatromanolaki, A, et al.
出版: (2004)

Transmembrane Domain Targeting Peptide Antagonizing ErbB2/Neu Inhibits Breast Tumor Growth and Metastasis
由: Alexia Arpel, et al.
出版: (2014-09-01)

Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors
由: Yasuhiro Nagai, et al.
出版: (2015-10-01)

Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors
由: Yasuhiro Nagai, et al.
出版: (2015-09-01)

Cross-regulation between FOXA1 and ErbB2 Signaling in Estrogen Receptor-Negative Breast Cancer
由: Ali Naderi, et al.
出版: (2012-04-01)

Cyanidin-3-Glucoside inhibits ethanol-induced invasion of breast cancer cells overexpressing ErbB2
由: Wang Shiow, et al.
出版: (2010-10-01)

Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
由: Bella Kaufman, et al.
出版: (2008-03-01)

Farnesyltransferase inhibitors as radiation sensitizers
由: Mckenna, W
出版: (2005)

Farnesyltransferase inhibitors as radiation sensitizers.
由: Brunner, T, et al.
出版: (2003)

Farnesyltransferase inhibitors as radiation sensitizers.
由: Mckenna, W, et al.
出版: (2002)